This Week in Science

In Science this week, a team from Memorial Sloan-Kettering Cancer Center reports on its discovery of genetic mutations that improve the clinical response to the cancer drug everolimus. The researchers sequenced the genome of a metastatic bladder cancer patient who had shown a complete and long-lasting response to the drug, which targets the signaling protein mTORC1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PNAS

This Week in Nature

This Week in Cell

This Week in PLOS

Here's Why

Viral Studies

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.